Skip to content
healthcare.dev

Metaxalone

NDC 50228-323, Metaxalone, tablet, from ScieGen Pharmaceuticals, Inc..

Product NDC
50228-323
Status
Listed
Labeler
ScieGen Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207466
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50228-323 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METAXALONE800 mg/1

Pharmacologic classes

Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]

Package NDCNDC-11Package
50228-323-0150228032301100 TABLET in 1 BOTTLE (50228-323-01)
50228-323-0550228032305500 TABLET in 1 BOTTLE (50228-323-05)
50228-323-305022803233030 TABLET in 1 BOTTLE (50228-323-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels?ndc=50228-323
  • NADAC price for package 50228032301

    GET /v1/drugs/nadac/50228032301
  • NADAC price for package 50228032305

    GET /v1/drugs/nadac/50228032305

Use it

Look up 50228-323 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50228-323 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50228-323. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.